Smith, Charlotte
Touzart, Aurore
Simonin, Mathieu
Tran-Quang, Christine
Hypolite, Guillaume
Latiri, Mehdi
Andrieu, Guillaume P.
Balducci, Estelle
Dourthe, Marie-Émilie
Goyal, Ashish
Huguet, Françoise
Petit, Arnaud
Ifrah, Norbert
Baruchel, André
Dombret, Hervé
Macintyre, Elizabeth
Plass, Christoph
Ghysdael, Jacques
Boissel, Nicolas
Asnafi, Vahid
Funding for this research was provided by:
Fondation pour la Recherche Médicale (FDT202012010638)
Institut National Du Cancer ([PLBIO 2021-1], [PLBIO-04] and [PRT-K 18-071])
Ligue Contre le Cancer
La Fondation de France (Post Doctorate Research Fellowship)
Cancer Research For Personalized Medicine
Fondation ARC pour la Recherche sur le Cancer (PGA_RC 2020 ROUSSELOT)
Article History
Received: 21 November 2022
Accepted: 16 December 2022
First Online: 18 January 2023
Declarations
:
: All blood or bone marrow samples were collected at diagnosis with patients’ informed consent. The GRAALL-2003,-2005 trials (#NCT00222027; #NCT00327678) and the FRALLE 2000 trials were conducted according to the declaration of Helsinki.Animal experimentation was evaluated and approved by the Institute’s ethics committee and the Ministère de l’enseignement supérieur de la recherche et de l'innovation. (PROJET APAFIS # 8853 N° 2017020814103710).
: Not applicable.
: The authors declare that they have no competing interests.